HitGen Inc
SSE:688222
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
HitGen Inc
Tax Provision
HitGen Inc
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
HitGen Inc
SSE:688222
|
Tax Provision
-¥16.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Tax Provision
-¥4.6B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-64%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Tax Provision
-¥357.5m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Tax Provision
-¥1.5B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Tax Provision
-¥198.2m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-16%
|
|
|
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
Tax Provision
-¥256.1m
|
CAGR 3-Years
-86%
|
CAGR 5-Years
-111%
|
CAGR 10-Years
N/A
|
|
HitGen Inc
Glance View
HitGen, Inc. engages in the provision deoxyribonucleic acid encoded compound library (DEL) for research and development of seed and lead compounds. The company is headquartered in Chengdu, Sichuan and currently employs 508 full-time employees. The company went IPO on 2020-04-16. The firm focuses on the research and creation of deoxyribonucleic acid encoded compound library (DEL) technology, research and development of hit compounds and lead compounds. The firm mainly provides DEL screening services, DEL library customization services, chemical synthesis services and transfer of new drug research and development projects. The firm conducts its businesses within the domestic market and to overseas markets.
See Also
What is HitGen Inc's Tax Provision?
Tax Provision
-16.1m
CNY
Based on the financial report for Mar 31, 2025, HitGen Inc's Tax Provision amounts to -16.1m CNY.
What is HitGen Inc's Tax Provision growth rate?
Tax Provision CAGR 5Y
-15%
